Spectramed Releases Guardian Unity

Friday, March 8, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

A developer of continuing education and rehabilitation products focused on dysphagia rehabilitation (swallowing disorders), today announced the release of Unity™, a two channel neuro-muscular stimulation device designed specifically for the treatment and rehabilitation of the swallowing musculature. Unity is the first stimulator that combines both Guardian Dysphagia Therapy® & VitalStim® Therapy.

COLUMBUS, Ohio, March 8, 2019 /PRNewswire-PRWeb/ -- Guardian dysphagia therapy treatments last 30 minutes and are performed

usually in a rehab clinic by a certified Speech Language Pathologist. Therapy is performed utilizing neuro-muscular electrical stimulation (NMES) to promote improved strength, timing, and reeducation of muscles used for swallowing.

"We are especially excited to release Unity because it is a unique device that combines two different clinical philosophies into one tool. It's exciting because I know our partners and their patients will greatly benefit from our new family of American Made devices," said Vice-President of Sales, Matt Favazzo

About Spectramed, LLC.

For thirty years, Spectramed, LLC., has manufactured, supplied and distributed a broad range of industry-leading product lines across a continuum of rehabilitation medical care. A leading provider of electrotherapy and education courses with a focus on Dysphagia and swallowing disorders. Spectramed services the needs of in-patient/out-patient hospitals, skilled nursing facilities, clinics, private practice, home health and re-sellers. Headquartered in Columbus, O.H., Spectramed continually develops new products in the areas of pain management, post-surgery recovery, sports medicine, evaluation and assistive devices. Our leading assistive products include Aspire2 sEMG/NMES and Guardian Therapy electrodes.

 

SOURCE Spectramed



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store